These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5090338)

  • 1. Enzyme alterable alkylating agents. XI. Clinical trials of an esterase-susceptible water-soluble agent (S-73) for regional chemotherapy.
    Bakal D; Goodman LE; Ulfohn A; Mamaril AG; Caplan YH; Calle S; Bhagavan BS; Witten B; Williamson CE; Sass S; Seligman AM
    J Surg Res; 1971 May; 11(5):217-23. PubMed ID: 5090338
    [No Abstract]   [Full Text] [Related]  

  • 2. Enzyme alterable alkylating agents. X. Experimental study of an esterase-susceptible water-soluble agent (S-73) for regional chemotherapy.
    Ulfohn A; Kramer SP; Calle S; Sass S; Williamson CE; Witten B; Seligman AM
    J Surg Res; 1968 Aug; 8(8):345-59. PubMed ID: 5667860
    [No Abstract]   [Full Text] [Related]  

  • 3. Preliminary study of an esterase-susceptible water-soluble agent (S-73) for regional chemotherapy.
    Goodman LE; Ulfohn A; Kramer SP; Calle S; Bakal D; Madamba R; Witten B; Williamson CE; Sass S; Seligman AM
    Cancer; 1967 May; 20(5):826-8. PubMed ID: 6024292
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical observation on the effect of perfusion of drugs through the internal iliac artery in cervix cancer].
    Zhonghua Yi Xue Za Zhi; 1973; 9():525-7. PubMed ID: 4200757
    [No Abstract]   [Full Text] [Related]  

  • 5. SYSTEMIC THIOSULFATE PROTECTION DURING FRACTIONATED REGIONAL NITROGEN MUSTARD THERAPY.
    LAWRENCE W; TAYAO MS; MAHAJAN RD; PAGE R; MILLER DG; CLAPP P
    J Surg Res; 1964 Nov; 4():483-94. PubMed ID: 14224011
    [No Abstract]   [Full Text] [Related]  

  • 6. Alkylating agents in bronchogenic carcinoma.
    Green RA; Humphrey E; Close H; Patno ME
    Am J Med; 1969 Apr; 46(4):516-25. PubMed ID: 5791000
    [No Abstract]   [Full Text] [Related]  

  • 7. Intra-arterial chemotherapy in advanced pelvic tumors.
    Gorgun B; Goplerud DR; Watne AL
    Arch Surg; 1967 Feb; 94(2):251-7. PubMed ID: 6016273
    [No Abstract]   [Full Text] [Related]  

  • 8. [On chemotherapy of neoplasms with regional perfusion].
    Husvéti S; Besznyák I
    Acta Chir Acad Sci Hung; 1966; 7(4):351-9. PubMed ID: 5965423
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of Hodgkin's disease and other cancers with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
    Marsh JC; DeConti RC; Hubbard SP
    Cancer Chemother Rep; 1971 Dec; 55(5):599-606. PubMed ID: 4334161
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of preliminary experiences with the use of Peptichemio administered by intra-arterial route in the treatment of tumors of the portio].
    Scarabelli C; Savi C
    G Ital Chemioter; 1974; 21(1):49-52. PubMed ID: 4466712
    [No Abstract]   [Full Text] [Related]  

  • 11. The current management of malignancy -- VI other solid tumors.
    Panettiere FJ
    Alaska Med; 1977 Mar; 19(2):19-25. PubMed ID: 326087
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of inoperable cancer of the lung, bladder and liver by means of intra-arterial administration of alkylating agents and application of remote control vessel tourniquet; a preliminary report.
    Jozef Z; Tadeusz J
    Pol Med Sci Hist Bull; 1966 Oct; 9(4):178-80 passim. PubMed ID: 5920141
    [No Abstract]   [Full Text] [Related]  

  • 13. Can chemotherapeutic perfusion of pelvic viscera palliate patients with advanced or recurrent cervical cancer?
    Bateman JC
    JAMA; 1965 Oct; 194(3):277. PubMed ID: 4158081
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy of gynecologic cancer with nitrosoureas: a randomized trial of CCNU and methyl-CCNU in cancers of the cervix, corpus, vagina, and vulva.
    Omura GA; Shingleton HM; Creasman WT; Blessing JA; Boronow RC
    Cancer Treat Rep; 1978 May; 62(5):833-5. PubMed ID: 350400
    [No Abstract]   [Full Text] [Related]  

  • 15. REGIONAL CHEMOTHERAPY IN MALIGNANT DISEASE: A REVIEW OF FIFTEEN CASES.
    ARDAGH JW; FOX HW; SKELTON CC
    N Z Med J; 1963 Dec; 62():611-8. PubMed ID: 14106416
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of bleomycin on squamous cell carcinoma: preliminary observations.
    Van Rooyen CE; Haldane EV
    N S Med Bull; 1972 Oct; 51(5):144-50. PubMed ID: 4116503
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of cytotoxic drugs in the surgery of malignant disease.
    Watt J
    J Bone Joint Surg Br; 1968 Aug; 50(3):511-23. PubMed ID: 4303179
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical use of Peptichemio: intra-arterial loco-regional infusion].
    Agresti A
    G Ital Chemioter; 1974; 21(1):44-6. PubMed ID: 4619388
    [No Abstract]   [Full Text] [Related]  

  • 19. [First case of simultaneous association of high energy radiotherapy and intra-arterial injections of nitrogen mustard compounds].
    Chevalier P; Minet P; Lavigne J
    J Belge Radiol; 1965; 48(5):586-92. PubMed ID: 4954296
    [No Abstract]   [Full Text] [Related]  

  • 20. CONTINUOUS INTRA-ARTERIAL OR INTRAVENOUS INFUSION OF 5-FLUORO-2-DEOXYURIDINE: THERAPEUTIC AND TOXIC EFFECTS.
    OETTGEN HF; CLIFFORD P; CANDLER P
    Cancer Chemother Rep; 1963 Oct; 32():35-46. PubMed ID: 14088834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.